The COL4A5 gene encodes the alpha5 (type IV) collagen chain and is defective in X-linked Alport syndrome (AS). Here, we report the first systematic analysis of all 51 exons of COL4A5 gene in a series of 201 Italian AS patients. We have previously reported nine major rearrangements, as well as 18 small mutations identified in the same patient series by SSCP analysis of several exons. After systematic analysis of all 51 exons of COL4A5, we have now identified 30 different mutations: 10 glycine substitutions in the triple helical domain of the protein, 9 frameshift mutations, 4 in-frame deletions, 1 start codon, 1 nonsense, and 5 splice-site mutations. These mutations were either unique or found in two unrelated families, thus excluding the presence of a common mutation in the coding part of the gene. Overall, mutations were detected in only 45% of individuals with a certain or likely diagnosis of X-linked AS. This finding suggests that mutations in noncoding segments of COL4A5 account for a high number of X-linked AS cases. An alternative hypothesis is the presence of locus heterogeneity, even within the X-linked form of the disease. A genotype/phenotype comparison enabled us to better substantiate a significant correlation between the degree of predicted disruption of the alpha5 chain and the severity of phenotype in affected male individuals. Our study has significant implications in the diagnosis and follow-up of AS patients.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1915065PMC

Publication Analysis

Top Keywords

exons col4a5
12
col4a5 gene
12
analysis exons
12
x-linked alport
8
alport syndrome
8
systematic analysis
8
mutations
7
x-linked
5
col4a5
5
syndrome sscp-based
4

Similar Publications

Article Synopsis
  • - Alport syndrome (AS) is a genetic disorder linked to mutations in the COL4A5 gene, leading to chronic kidney disease, with no specific treatment available yet.
  • - Researchers conducted a study using kidney organoids from AS patient-derived stem cells (AS-iPSCs) and discovered that exon skipping could partially restore the missing COL4A5 protein in lab tests.
  • - Despite the potential success in vitro, when AS-organoids were transplanted into mice, they showed minimal effects in improving kidney structure compared to control organoids, indicating more research is needed.
View Article and Find Full Text PDF

Nonsyndromic sporadic thoracic aortic aneurysm (nssTAA) is characterized by diverse genetic variants that may vary in different populations. Our aim was to identify clinically relevant variants in genes implicated in hereditary aneurysms in Russian patients with nssTAA. Forty-one patients with nssTAA without dissection were analyzed.

View Article and Find Full Text PDF
Article Synopsis
  • Alport Syndrome (AS) is a genetic kidney disorder primarily inherited in an X-linked dominant manner, characterized by progressive hearing loss and atypical eye symptoms, with limited effective therapies available.
  • A new splice variant of the COL4A5 gene, c.4822-10T>C, was identified, affecting mRNA production and leading to a truncated protein that disrupts normal function.
  • The study highlights the role of this splice variant in activating nonsense-mediated mRNA decay, resulting in decreased mRNA expression and insufficient protein synthesis, which could explain the severity of symptoms in XLAS patients.
View Article and Find Full Text PDF

Trimerization profile of type IV collagen COL4A5 exon deletion in X-linked Alport syndrome.

Clin Exp Nephrol

September 2024

Department of Molecular Medicine, Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Chuo-ku, Kumamoto City, 862-0973, Japan.

Article Synopsis
  • Alport syndrome (AS) is a genetic kidney disease linked to mutations in type IV collagen, specifically the α3, α4, and α5 chains, with severe forms caused by nonsense mutations.
  • An exon-skipping method developed to remove these mutations showed promise in alleviating AS pathology, but its effects on trimerization (the process of forming collagen structures) had not been fully understood.
  • The study revealed that exon deletion can affect collagen trimer secretion differently, with some deletions enabling normal trimer formation and secretion while others hindered it, highlighting potential therapeutic strategies for AS but with limitations based on the specific deletions' impacts on secretion.
View Article and Find Full Text PDF

Background: X-linked Alport syndrome (XLAS) is an inherited renal disease caused by rare variants of COL4A5 on chromosome Xq22. Many studies have indicated that single nucleotide variants (SNVs) in exons can disrupt normal splicing process of the pre-mRNA by altering various splicing regulatory signals. The male patients with XLAS have a strong genotype-phenotype correlation.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!